Polyphor's Unattributed Round

Polyphor raised a round of funding on April 12, 2017.

Polyphor is a clinical-stage Swiss specialty pharma company focused on the development of macrocycle drugs addressing antibiotic resistance and respiratory diseases. The company's lead drug candidates…

Articles about Polyphor's Unattributed Round: